SARS-CoV-2 neutralizing antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SARS-CoV-2 neutralizing antibody, covering 2022-01-27 to 2022-01-27. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants [Phase 1]